Saturday 17 October 2026 Export VVOS’s income statement to Excel — free account

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 million, up 16.0% from fiscal 2024. In the quarter to June 2026, revenue grew 34.9%, EPS grew 43.6%, free cash flow grew 16.4% and total debt rose 2.79%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.13 0.01 −7.14%

Follow VVOS

Alert me

Market cap: $4.8M
P/E: 0.0×
Fwd P/E: −0.5×
Dividend yield: —
F-score: 2/9
Altman Z: −9.08
Beneish M: −1.44
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	2	2	2	+8 more TTM periods Free account
ROE Full definition →	10,022.05%	(1,470.75%)	(661.15%)	(335.47%)
ROA Full definition →	(101.46%)	(137.58%)	(104.71%)	(83.45%)
ROIC Full definition →	(592.70%)	(325.33%)	(237.15%)	(124.97%)
Return on Tangible Assets Full definition →	203.06%	260.51%	213.09%	(428.56%)
Average Days of Receivables Full definition →	25.11	33.00	33.08	44.98
Free Cash Flow per Share Full definition →	(1.08)	(1.35)	(1.71)	(1.40)
Free Cash Flow Full definition →	(19.01)	(19.71)	(17.60)	(15.37)
Capital Expenditures Full definition →	(1.88)	(2.24)	(2.34)	(0.97)
Other line items
Cash ROIC Full definition →	(320.84%)	(230.30%)	(189.27%)	(107.18%)
Accounts Receivable Turnover Full definition →	13.61	15.74	17.35	13.38
Accounts Payable Turnover Full definition →	3.38	4.67	4.97	4.82
Inventory Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	134.98	97.45	88.80	100.16
Days of Inventory on Hand Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	161.22%	169.14%	166.98%	144.16%
Share Based Compensation of Revenue Full definition →	4.25%	5.16%	3.79%	3.90%
Operating CF/Net income Full definition →	0.67	0.70	0.72	0.84
Depreciation/Fixed assets Full definition →	0.49	0.45	0.35	0.18
Capex/Depreciation Full definition →	(1.05)	(1.41)	(1.79)	(0.96)
Revenue per Share Full definition →	1.18	1.34	1.70	1.58
Operating CF per Share Full definition →	(0.97)	(1.19)	(1.49)	(1.31)
Capex per Share Full definition →	(0.11)	(0.15)	(0.23)	(0.09)
Capex to Sales Full definition →	0.09	0.11	0.13	0.06

Show all line items

Columns are period end dates

Stockrow Weekly